Nephros, Inc. (NASDAQ:NEPH) issued its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Bloomberg Earnings reports. The business had revenue of $0.86 million during the quarter. Nephros had a negative return on equity of 267.27% and a negative net margin of 92.64%.
Shares of Nephros (NASDAQ NEPH) traded up 2.083% during midday trading on Thursday, reaching $0.245. The company’s stock had a trading volume of 28,645 shares. The company’s market cap is $13.27 million. Nephros has a 12-month low of $0.18 and a 12-month high of $0.60. The stock’s 50-day moving average price is $0.25 and its 200-day moving average price is $0.34.
About Nephros
Nephros, Inc (Nephros) is a commercial-stage medical device and commercial products company that develops and sells high performance liquid purification filters and hemodiafiltration (HDF) systems. The Company’s filters, ultrafilters, are primarily used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate, and used in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas.
Receive News & Ratings for Nephros Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
